CSS - Lab Equipment for Generation/Analysis

Closed Solicitation Posted

Solicitation number
75N98026Q01145
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health, National Heart, Lung, and Blood Institute, seeks three specific pieces of commercially available laboratory equipment for lipid nanoparticle generation and analysis supporting in vivo gene therapy research, with responses due September 14, 2026 at 3:00 PM EDT. This is an unrestricted, full and open competition conducted as a streamlined commercial acquisition under FAR 12.603, not expected to exceed the simplified acquisition threshold, and will result in a firm-fixed-price purchase order.

Place of performance is 9000 Rockville Pike, Building 10, Room 8N110, Bethesda, Maryland 20892, with delivery required as soon as possible after award. The three items are: one Ignite+ Upgrade Kit (compatible with the Government's existing Ignite device, increasing working volume to 60 mL and flow rate to 200 mL/min, 16.5 kg, dimensions 38 x 34 x 38 cm); one AKTA flux S Semi-Automated Tangential Flow Filtration System (25 kg, 40 x 45 x 55 cm, 400W power requirement); and one VIA Freeze Duo Controlled Rate Freezer (40 kg, 44.6 x 38.3 x 61 cm, requiring 93.7 cm vertical clearance). The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. Evaluation criteria are technical capability (meeting salient characteristics), past performance on comparable orders, delivery schedule, and price, with technical capability, past performance, and delivery schedule combined being approximately equal to price. Responses must include unit and total pricing, shipping costs, delivery timeframe in calendar days, delivery terms, F.O.B. point, manufacturer and model information, descriptive literature demonstrating compliance, warranty terms, UEI, TIN, and business size certification. Point of contact: Nicholas Capobianco, Contracting Specialist, nicholas.capobianco@nih.gov.

Notice text

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance
with FAR Subpart 12.6, as supplemented with additional information included in this
notice. This announcement constitutes the only solicitation; proposals are being
requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q01145. This solicitation is issued as a competitive
combined synopsis/solicitation for commercial products or commercial services. The
Government intends to award a contract or purchase order resulting from this solicitation
using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation
for Commercial Products or Commercial Services, and is not expected to exceed the
simplified acquisition threshold.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks
to award a firm-fixed-price purchase order to the responsible offeror whose proposal
represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect
through Federal Acquisition Circular 2026-01, effective 03/13/2026.
(iv) The associated NAICS code is 334516 ¿ Analytical Laboratory Instrument
Manufacturing, and the small business size standard is 1,000 employees.
¿ This requirement is unrestricted.
(v) Description of Requirement:
The National Heart, Lung, and Blood Institute (NHLBI) requires the following commercially
available laboratory equipment to support research on hematopoietic stem cell (HSC)-
targeted lipid nanoparticle (LNP) gene delivery for the advancement of in vivo gene therapy.
Offerors shall provide equipment meeting or exceeding the salient characteristics below.

Files

File Type Posted
Sol_75N98026Q01145.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
NOI - A Non-Invasive Prognostic Biomarker - Circul NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
NOI - INOVA/NHLBI Biobanking in Hospitalized Patients Virginia 22042, United States · NAICS 622110 Office of Logisitics and Acquisition Operations No set-aside
NOI - A Non-Invasive Prognostic Biomarker NAICS 541714 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity